Inhibition of Shp2/PTPn11 Protein Tyrosine Phosphatase By Nsc-117199 and Analogs
Protein tyrosine phosphatase (PTP) Shp2 is a non-receptor PTP that involved in cell signaling and regulation of cell proliferation, differentiation, and migration. Shp2 mediates activation of kinases that are involved in the pathogenesis of human carcinoma. NSC-117199 was identified as a porent inhibitor of the protein tyrosine phosphatase (PTPa) Shp2. A focused library of analogs incorporating an isatin scaffold was designed and evaluated for inhibition of Shp2 and Shp1 PTP activities. Several compounds were identified that selectively inhibit Shp2 over Shp1 and PTP1B with low to sub-micromolar activity. Also disclosed are methods of inhibiting a protein tyrosine phosphatase in a cell and treating cancer through selective inhibition of Shp2.
WO 2,009,135,000 [MORE INFO
WU JIE [US]; LAWRENCE NICHOLAS J [US]; SEBTI SAID M [US]; LAWRENCE HARSHANI R [US]
Type of Offer:
« More Biotech Patents